Exosomes Overexpressing CD24
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Exosomes Overexpressing CD24, covering 2021-06-15 to 2021-07-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection [Phase 2]